Novartis Pharmaceuticals Corporation et al v. Lotus Pharmaceutical Co., Ltd. et al > Summary
Court Case Number 1:21-cv-01107
Filing Date Jul 30, 2021
Termination Date Dec 12, 2023
Court Delaware District Court
Status Dismissed - Settled
JudgesMaryellen Noreika
Plaintiff Attorneys
21Novartis
Attorney Name: Anne Y. Brody
Gibson Dunn & Crutcher
Novartis
Attorney Name: Alexandra M. Joyce
McCarter & English
Novartis
Attorney Name: Ronald A. Lee
Gibson Dunn & Crutcher
Novartis
Attorney Name: Sung Bin Lee
Gibson Dunn & Crutcher
Novartis
Attorney Name: Jane M. Love
Gibson Dunn & Crutcher
Novartis
Attorney Name: Daniel M. Silver
McCarter & English
Dana-Farber Cancer Institute
Attorney Name: Anne Y. Brody
Gibson Dunn & Crutcher
Dana-Farber Cancer Institute
Attorney Name: Alexandra M. Joyce
McCarter & English
Dana-Farber Cancer Institute
Attorney Name: Ronald A. Lee
Gibson Dunn & Crutcher
Dana-Farber Cancer Institute
Attorney Name: Sung Bin Lee
Gibson Dunn & Crutcher
Dana-Farber Cancer Institute
Attorney Name: Jane M. Love
Gibson Dunn & Crutcher
Dana-Farber Cancer Institute
Attorney Name: Daniel M. Silver
McCarter & English
Novartis
Attorney Name: Emil N. Nachman
Gibson Dunn & Crutcher
Dana-Farber Cancer Institute
Attorney Name: Emil N. Nachman
Gibson Dunn & Crutcher
Novartis
Attorney Name: Robert W. Trenchard
Gibson Dunn & Crutcher
Dana-Farber Cancer Institute
Attorney Name: Robert W. Trenchard
Gibson Dunn & Crutcher
Novartis
Attorney Name: Kyanna A. Sabanoglu
Gibson Dunn & Crutcher
Novartis
Attorney Name: Renaud Capdeville
Novartis
Novartis
Attorney Name: Mark J. Levis
Novartis
Novartis
Attorney Name: Jyoti Sachdeva
Novartis
Novartis
Attorney Name: Stephen R. Byrn
Novartis
Defendant Attorneys
24LOTUS PHARMACEUTICAL CO., LTD.
Attorney Name: Keelin D. Bielski
Leydig, Voit & Mayer
LOTUS PHARMACEUTICAL CO., LTD.
Attorney Name: Dominick T. Gattuso
Heyman Enerio Gattuso & Hirzel
LOTUS PHARMACEUTICAL CO., LTD.
Attorney Name: Jeremy C. Lowe
Leydig, Voit & Mayer
LOTUS PHARMACEUTICAL CO., LTD.
Attorney Name: James W. Sanner
Leydig, Voit & Mayer
LOTUS PHARMACEUTICAL CO., LTD.
Attorney Name: Steven H. Sklar
Leydig, Voit & Mayer
Teva Pharmaceuticals
Attorney Name: Steven M. Coyle
Cantor Colburn
Teva Pharmaceuticals
Attorney Name: Nicholas A. Geiger
Cantor Colburn
Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Karen E. Keller
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Katherine M. Tassmer
Cantor Colburn
Teva Pharmaceuticals
Attorney Name: Gregory C. Bays
Leydig, Voit & Mayer
Teva Pharmaceuticals
Attorney Name: James W. Sanner
Leydig, Voit & Mayer
Teva Pharmaceuticals
Attorney Name: Jeremy C. Lowe
Leydig, Voit & Mayer
Teva Pharmaceuticals
Attorney Name: Keelin D. Bielski
Leydig, Voit & Mayer
Teva Pharmaceuticals
Attorney Name: Steven H. Sklar
Leydig, Voit & Mayer
Teva Pharmaceuticals
Attorney Name: Nicholas A. Geiger
Axinn Veltrop & Harkrider
Teva Pharmaceuticals
Attorney Name: Tunie Zaku
Teva Pharmaceuticals
Teva Pharmaceuticals
Attorney Name: Frederick H. Hausheer
Teva Pharmaceuticals
Teva Pharmaceuticals
Attorney Name: Bernard Domnic
Teva Pharmaceuticals
Teva Pharmaceuticals
Attorney Name: Danielle Kornitzer
Teva Pharmaceuticals
LOTUS PHARMACEUTICAL CO., LTD.
Attorney Name: Denise Seastone Kraft
Heyman Enerio Gattuso & Hirzel
LOTUS PHARMACEUTICAL CO., LTD.
Attorney Name: Ashlee B. Szelag
Leydig, Voit & Mayer
Lupin Pharmaceuticals
Attorney Name: James M. Lennon
Devlin Law Firm
Cause
35:1 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08575146 | Pharmaceutical uses of staurosporine derivatives | Nov 5, 2013 |
| 08222244 | Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity | Jul 17, 2012 |
| 07973031 | Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity | Jul 5, 2011 |
| 05932243 | Galenical formulations | Aug 3, 1999 |
| 05093330 | Staurosporine derivatives substituted at methylamino nitrogen | Mar 3, 1992 |
